Pediatrix Medical Group, Inc. New Standards Disclosure
New Accounting Pronouncement
In December 2023, accounting guidance related to income tax disclosures was issued which requires additional disclosure in the Company’s effective tax rate reconciliation, including additional details for reconciling items that meet a quantitative threshold. The accounting guidance also requires enhanced disclosures for income taxes paid disaggregated by federal and state jurisdictions, with further disaggregation required for individual state
jurisdictions that meet a quantitative threshold. The guidance became effective for the Company on its Form 10-K for the year ended December 31, 2025 and may be applied prospectively or retrospectively. The Company elected to adopt this standard prospectively for the year ended December 31, 2025. The adoption of this standard had no impact to our results of operations, cash flows, or financial condition.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 19, 2026 | Showing above |
| 2021 | Feb 17, 2022 | |
| 2020 | Feb 18, 2021 | |
| 2019 | Feb 20, 2020 | |
| 2018 | Feb 14, 2019 | |
| 2017 | Feb 14, 2018 | |
| 2016 | Feb 10, 2017 | |
| 2015 | Feb 11, 2016 | |
About New Standards Disclosures
New accounting standards disclosures describe recently adopted pronouncements and those not yet effective, along with management's assessment of their expected impact. This section provides an early warning system for upcoming changes to how a company reports its financial results, often years before the new rules take effect.
Key signals: when management describes a not-yet-adopted standard's impact as "material" or "still being evaluated," it signals potential significant changes to reported metrics upon adoption. Watch for standards that affect a company's core operations — for example, revenue recognition changes for software companies or lease accounting changes for retailers with large store footprints. The transition method chosen (full retrospective versus modified retrospective) affects comparability with prior periods. Companies that delay adoption to the latest permitted date may be struggling with implementation complexity. Compare the disclosed impact assessments against peers in the same industry to gauge whether management's expectations are reasonable.